Can Treating Depression Improve Disease Outcomes?
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Editorials15 June 2004Can Treating Depression Improve Disease Outcomes?FREEJeffrey L. Jackson, MD, MPH, Kent DeZee, MD, and Elizabeth Berbano, MD, MPHJeffrey L. Jackson, MD, MPHFrom Uniformed Services University of the Health Sciences, Bethesda, MD 20814., Kent DeZee, MDFrom Uniformed Services University of the Health Sciences, Bethesda, MD 20814., and Elizabeth Berbano, MD, MPHFrom Uniformed Services University of the Health Sciences, Bethesda, MD 20814.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-140-12-200406150-00017 SectionsAboutVisual AbstractPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail The separation of the mind and body, a legacy that can be traced from Greek philosophers to Descartes' Meditations to modern western thought, is reflected in the attitudes and practices of western medicine. This partitioning of mental disorders as processes of the mind, separate and distinct from processes of the body, is increasingly subject to challenge. An article in this issue (1) tests the validity of partitioning mental and physical processes by assessing the effect of treatment for depression on diabetic care outcomes.Depression is a profound source of human suffering worldwide. It is common among patients with chronic pain and frequently develops after the onset of other medical conditions, such as heart attacks, strokes, malignant disease, osteoporosis, heart failure, liver disease, end-stage renal disease, and rheumatologic disorders. We aren't surprised when a person becomes depressed after developing a life-altering, chronic, disabling, or painful medical condition. Some of us are surprised by evidence that depression associated with chronic medical conditions leads to worse outcomes for the chronic illness. For example, patients with depression after myocardial infarction or stroke are more likely to die (2), and depressed, diabetic patients have worse glycemic control (3) and higher rates of diabetic complications (4). Most of us would be startled to learn of emerging evidence that depression may increase the risk for subsequent development of many health conditions, including osteoporosis (5), coronary artery disease (6), diabetes (7), and cerebral vascular disease (8). Although it is only logical to believe that treating depression might improve outcomes for these health conditions, this conjecture is still unproven.By what mechanism does a process of the mind affect the outcome of processes of the body? The usual explanations are that depression reduces adherence to care recommendations and is associated with negative health behaviors, such as smoking and less exercise (9, 10). These explanations may apply to some situations, but in most cases, the answer is probably far more complex. Depression adversely affects many physiologic processes, including autonomic dysregulation (11), inflammation (12), insulin resistance (13), platelet aggregation, and decreased cellular immunity (14). Some studies have shown that markers of inflammation improve with treatment for depression. In addition, selective serotonin reuptake inhibitors seem to affect platelet aggregation, which suggests that treatment for depression may have other, as yet unobserved, beneficial effects.Although depression may precede, potentially cause, and worsen the prognosis for certain medical conditions, the critical question for clinicians is whether treating depression improves disease outcomes. This question is not simply pragmatic; reversibility would give researchers a lead in unraveling mechanisms of disease. Strong evidence suggests that treating major depression markedly improves depressive symptoms, health-related functioning, and the patient's quality of life. To date, no studies have studied whether treating depression can prevent the development of other conditions. A few studies have shown that depression treatment improves comorbid medical outcomes. Although observational studies have shown large effects, the effect seen in clinical trials has been smaller. For example, observational studies have shown a 3- to 4-fold increase in cardiac morbidity and mortality in patients with depression after myocardial infarction. In the only randomized, controlled trial of the effect of treating these depressed patients, sertraline reduced the risk by a statistically insignificant 5% (95% CI, −3.0% to 15%). However, this study's purpose was to examine the safety of sertraline after myocardial infarction rather than cardiovascular outcomes; it was small and short (24 weeks) and had too few outcome events to exclude a clinically important effect (15). A larger randomized, controlled trial that examined the effects of depression treatment on cardiovascular outcomes is ongoing (16). Similarly, observational trials have found a large increase in mortality among depressed patients after a stroke, whereas most clinical trials of depression treatment have
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Depression and poor glycemic control: a meta-analytic review of the literature.
Lustman, P. J., Anderson, R. J., Freedland, K. E., de Groot, M., Carney, R. M., & Clouse, R. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.934 · Cited by 1,854
Association of depression and diabetes complications: a meta-analysis
de Groot, M., Anderson, R., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200107000-00015 · Cited by 1,799 · cited 1×
“For example, patients with depression after myocardial infarction or stroke are more likely to die (2), and depressed, diabetic patients have worse glycemic control (3) and higher rates of diabetic complications (4).”
BackgroundDepression and Diabetes: Impact of Depressive Symptoms on Adherence, Function, and Costs
Ciechanowski, P. S., Katon, W. J., & Russo, J. E. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3278 · Cited by 1,465 · cited 1×
“By what mechanism does a process of the mind affect the outcome of processes of the body? The usual explanations are that depression reduces adherence to care recommendations and is associated with negative health behaviors, such as smoking and less exercise (9, 10).”
BackgroundSertraline treatment of major depression in patients with acute MI or unstable angina
Glassman, A. H. (2002) · JAMA · doi:10.1001/jama.288.6.701 · Cited by 1,414
Neuroanatomy of the pain system and of the pathways that modulate pain
Willis, W. D., & Westlund, K. N. (1997) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-199701000-00002 · Cited by 924 · cited 1×
“Depression medications with both norepinephrine and serotonin effects might be particularly effective in somatic syndromes because both norepinephrine and serotonin may modulate painful stimuli perception at the spinal cord level (21).”
BackgroundLustman, P. J., Griffith, L. S., Freedland, K. E., Kissel, S. S., & Clouse, R. E. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-8-199810150-00005 · Cited by 562
Cited by
Current Psychosomatic Practice
Fava, G. A., Cosci, F., & Sonino, N. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000448856 · Cited by 302
Restless Legs Syndrome, Periodic Limb Movements in Sleep, and Depression
(2005) · Sleep · doi:10.1093/sleep/28.7.891 · Cited by 247
Riekert, K. A., Bartlett, S. J., Boyle, M. P., Krishnan, J. A., & Rand, C. S. (2007) · Chest · doi:10.1378/chest.06-2474 · Cited by 197
Asthma and depression: a pragmatic review of the literature and recommendations for future research.
(2005) · Clinical Practice and Epidemiology in Mental Health · doi:10.1186/1745-0179-1-18 · Cited by 164
Metadata
- Authors
- Jackson, J. L., DeZee, K., & Berbano, E.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2004-06-15
- Volume
- 140
- Issue
- 12
- Pages
- 1054-1056
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2058189047
- Cited by
- 34
- References
- 6
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Can Treating Depression Improve Disease Outcomes? https://app.cochat.ai/papers/10.7326/0003-4819-140-12-200406150-00017
- The paper
- Jackson, J. L., DeZee, K., & Berbano, E. (2004). Can Treating Depression Improve Disease Outcomes? Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-140-12-200406150-00017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.